Speaking Tasks for Speech

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
SpeechSpeaking Tasks - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing how the brain processes and controls speech in healthy people in order to help those with communication disorders. 15 participants are needed for 3-4 visits lasting 2-4 hours each.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 0 Secondary · Reporting Duration: up to 1 hour

up to 1 hour
Speaking-Induced Suppression (SIS) defined as the z-score reduction in average M100 amplitude in the speak condition compared with the listen condition

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Healthy Adult Speakers
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Speaking Tasks · No Placebo Group · N/A

Healthy Adult SpeakersExperimental Group · 3 Interventions: Speaking Tasks, MEG/EEG, MRI · Intervention Types: Behavioral, Behavioral, Behavioral
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MRI
2009
Completed Phase 2
~1370

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: up to 1 hour

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,069 Previous Clinical Trials
2,576,426 Total Patients Enrolled
National Institute on Deafness and Other Communication Disorders (NIDCD)NIH
282 Previous Clinical Trials
175,469 Total Patients Enrolled
6 Trials studying Speech
690 Patients Enrolled for Speech
Carrie Niziolek, PhDPrincipal InvestigatorUniversity of Wisconsin, Madison

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are an adult of English-speaking ethnicity.
You are using a cochlear implant to hear.
You have normal hearing and are able to speak.
You have aphasia.